Pangenia Inc (“Pangenia Group” or “The Group”) is a leading molecular diagnostics (MDx) group in Hong Kong founded by Professor Joseph Wing-On Tam and Mr. Anthony Wong. Since the establishment in 2006 of DiagCor Bioscience Incorporation Limited (the founding member company), Pangenia Group has been working hard towards promoting a healthier society by researching, developing and commercializing MDx innovations.
Through the dedication of an elite group of forefront biotech scientists and executives, Pangenia Group’s patented DNA and RNA analysis techniques allow us to offer a wide variety of services and solutions to our valuable customers. Our laboratory services are specialized in genetic testing, including prenatal diagnosis, parentage investigation, cancer testing, infectious disease identification, and various hereditary risk assessments.
Pangenia Group actively works with commercial, institutional and governmental organizations across the world, remaining at the forefront of advanced molecular diagnostics, and educating the general public about the benefits of molecular diagnostics.
Over 10+ years of experience in molecular diagnostics industry;
Former HKSTP fund assessment panelist;
Former HKUST research project fund assessment panelist;
Master of Philosophy at the University of Hong Kong;
PhD at the National Institute for Basic Biology, Japan;
Member of Hong Kong Society for Molecular Diagnostic Sciences Ltd
Over two decades of drug discovery and development expertise in pharma and biotech companies including Amgen, ImClone/Lilly, deCODE, Genea Biocells;
diverse modalities in mid/late stages of clinical developments to treat oncology, CNS, metabolic and neuromuscular disorders with specific emphasis on rare diseases;
over 170 peer-reviewed publications and over 60 granted patents and patent applications
Head of Sales & Marketing;
Board Member of numerous Biotechnology companies in Hong Kong and China;
Over 20 years of project management and sales marketing;
BSLA; EMIL; MBA
Biotechnology Scientist;
Former Program Manager, Project Planning and Execution Group, Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI);
PhD, The Hong Kong Baptist University
Biochemistry Scientist;
Scientific Officer, The Chinese University of Hong Kong;
PhD, GradD, M.Phil., The Chinese University of Hong Kong
Honorary Associate Professor & Research Scientist, the University of Hong Kong;
Former Visiting Professor at University of California, San Francisco,
Baylor Medical College and Medical College of Georgia;
Former Scientist, National Institute of Health;
Founder and President of the Hong Kong Biochemistry Association;
Inventor & Patent Holder of Flow-through Hybridization Technology
Medical oncologist;
Distinguished Professor and Chair, Department of Biochemistry and Molecular Medicine, UC Davis Health School of Medicine;
Sue Jane Leung Presidential Chair in Cancer Research & Harold Albin Johnson Endowed Chair in Biomedical Research, UC Davis NCI-Designated Comprehensive Cancer Center;
PhD in Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin;
MD, Stanford University School of Medicine
Pharmacologist;
Research Scientist, Stanford University;
Honorary Associate Professor, the University of Hong Kong;
President & Founder of Apollonian Biosystems Ltd./ Inc., Hong Kong and USA; Patent Holder;
PhD, & M.S., Yale University;
M.S., Columbia University
Tsao Yen-Chow Endowed Professor & Head, Department of Paediatrics & Adolescent Medicine, the University of Hong Kong;
Chief of Service, Department of Paediatrics & Adolescent Medicine, Hong Kong Children's Hospital, HKU-Shenzhen Hospital & Gleneagles Hospital;
Deputy Director, Stem Cells & Regenerative Medicine Consortium;
Chief Commission Service Coordinator (Paediatric Oncology), Hong Kong Children's Hospital. DMD & MD, the University of the East
Former National Sales & Marketing Director, Bio-Rad Laboratories Canada;
Former Asia-Pacific Chairman & President, PerkinElmer;
Member of the Advisory Council on Food and Environment Hygiene of the HKSAR Government;
Tenth Council member, the Chinese People’s Political Consultative Conference in Jilin province;
Honorary Fellow, the Hong Kong University of Science and Technology
Co-Founder & Co-CEO of MaLogic;
Former Group Chairman, Ogilvy in Hong Kong and Southern China;
Former Council Member of The HK Trade Development Council & The HK Academy for Performing Arts;
Member of the Advisory Committee on Arts Development;
Vetting Committee Member of the SME Development Fund & BUD Fund;
Former Advisory Committee Member for the ICAC, HK Museum, CEDB and the Education Bureau. Vice-Chairman of Plan International (HK);
University Fellowship, the Hong Kong Polytechnic University